1. Home
  2. OGN vs CWEN Comparison

OGN vs CWEN Comparison

Compare OGN & CWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OGN
  • CWEN
  • Stock Information
  • Founded
  • OGN 1923
  • CWEN 2012
  • Country
  • OGN United States
  • CWEN United States
  • Employees
  • OGN N/A
  • CWEN N/A
  • Industry
  • OGN Biotechnology: Pharmaceutical Preparations
  • CWEN Electric Utilities: Central
  • Sector
  • OGN Health Care
  • CWEN Utilities
  • Exchange
  • OGN Nasdaq
  • CWEN Nasdaq
  • Market Cap
  • OGN 4.0B
  • CWEN 3.4B
  • IPO Year
  • OGN N/A
  • CWEN 2013
  • Fundamental
  • Price
  • OGN $14.73
  • CWEN $30.61
  • Analyst Decision
  • OGN Hold
  • CWEN Strong Buy
  • Analyst Count
  • OGN 5
  • CWEN 6
  • Target Price
  • OGN $20.80
  • CWEN $34.33
  • AVG Volume (30 Days)
  • OGN 3.8M
  • CWEN 1.1M
  • Earning Date
  • OGN 05-01-2025
  • CWEN 05-08-2025
  • Dividend Yield
  • OGN 7.61%
  • CWEN 5.50%
  • EPS Growth
  • OGN N/A
  • CWEN 10.45
  • EPS
  • OGN 3.33
  • CWEN 0.75
  • Revenue
  • OGN $6,403,000,000.00
  • CWEN $1,371,000,000.00
  • Revenue This Year
  • OGN N/A
  • CWEN $10.58
  • Revenue Next Year
  • OGN $0.71
  • CWEN $8.38
  • P/E Ratio
  • OGN $4.42
  • CWEN $41.04
  • Revenue Growth
  • OGN 2.23
  • CWEN 4.34
  • 52 Week Low
  • OGN $13.87
  • CWEN $21.72
  • 52 Week High
  • OGN $23.10
  • CWEN $30.92
  • Technical
  • Relative Strength Index (RSI)
  • OGN 46.35
  • CWEN 70.86
  • Support Level
  • OGN $14.81
  • CWEN $29.63
  • Resistance Level
  • OGN $14.94
  • CWEN $30.56
  • Average True Range (ATR)
  • OGN 0.52
  • CWEN 0.56
  • MACD
  • OGN -0.08
  • CWEN -0.01
  • Stochastic Oscillator
  • OGN 42.03
  • CWEN 92.50

About OGN Organon & Co.

Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars, and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

About CWEN Clearway Energy Inc. Class C

Clearway Energy Inc is a publicly-traded energy infrastructure investor with a focus on investments in clean energy and owner of modern, sustainable and long-term contracted assets across North America. The company segments its operations into Flexible Generation, renewables and Corporate divisions.

Share on Social Networks: